This echoes the clinical practice already emerging with semaglutide and tirzepatide, where some prescribers step patients down after target weight is achieved
She felt she was being productive for the first time in years
Ozempic: the truth about new weight-loss drugs Wegovy study finds weight-loss drug sharply cuts heart attacks, strokes and cardiac deaths What to do about fake weight-loss drugs and compounded versions Nutrition is vital when taking GLP-1 weight-loss drugs
Retatrutide: The New Triple-Agonist Weight Loss Treatment Medically reviewed by Dr Clair Grainger Last reviewed: 30 Dec 2025 Retatrutide is the latest weight loss medication thats currently in phase 3 clinical trials
Im trying to develop the lifestyle habits I know I need to start to lean into and be able to maintain because once I go off the medication, the biggest fear is that Ill gain it back resorting back to what got me to 50-plus pounds in January 2023, said Gee
Trevor Edmund Angell, University of Southern California, United States Updates Copyright 2022 Hu, Song, Cheng, Liu, Guo, Tang, Zhang, Zhao, Li and Liu